• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
MRC Laboratory of Molecular Biology

MRC Laboratory of Molecular Biology

One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

  • Home
  • About LMB
  • Research
  • Research Groups
  • Students
  • Recruitment
  • Life at the LMB
  • Achievements
  • News & Events
Home > News & Events > LMB News

LMB News

  • All
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009

Heptares Therapeutics Announces Agreement With Novartis Option Fund

Heptares Therapeutics Ltd, the drug discovery company focused on G-protein-coupled receptor (GPCR) targets, has recently announced that it has entered into an option agreement with the Novartis Option Fund under which Heptares will apply its proprietary StaR(TM) technology to generate novel drug leads against a nominated, unspecified GPCR target of interest to Novartis. The agreement includes upfront and potential milestone payments to Heptares totaling up to $200 million plus royalties.

More…

Published on 12th October, 2009

Dr Venki Ramakrishnan wins 2009 Nobel Prize for Chemistry

This year’s chemistry Nobel Prize has been awarded to Dr Venki Ramakrishnan of LMB for “studies of the structure and function of the ribosome”.
Venki Ramakrishnan shares the honour with Thomas A. Steitz (Yale University) and Ada E. Yonath (Weizmann Institute of Science, Israel). The trio showed how the information encoded on strands of DNA is translated into the proteins of life.

More…

Published on 7th October, 2009

Human Antibodies developed for Treatment of Lupus and Anthrax

Two therapies with their roots in antibody technology developed in the LMB and the Scripps Research Institute* have recently emerged as promising new drug candidates to treat lupus, a potentially fatal autoimmune disease, and anthrax, a pressing concern due to bioterrorism.

More…

Published on 31st July, 2009
  • «
  • ‹
  • 71
  • 72
  • 73

Primary Sidebar

News & Events

  • Insight on Research
  • LMB News
  • LMB In The News
  • LMB Alumni News
  • Public Engagement
    • Supporting Education
      • I’m a scientist, get me out of here!
      • London International Youth Science Forum
    • LMB on the Road
      • Cambridge Festival
      • Royal Society Summer Science Exhibitions
      • Big Biology Day
      • LifeLab
    • Events at the LMB
      • Artists in Residence: Home in the Service of Science
      • LMB Open Day 2017
      • STEM in Song
    • Resources
      • Image Game
    • LMB Science Stories
      • Electron Cryo-microscopy
      • Tau and Alzheimer’s
    • Past Events
      • MRC Festival of Research
      • Crystal Growing Competition
        • Past Winners
        • MRC Lab Visits
      • The WormWatch Lab
    • Contact Us
  • Scientific Seminars
    • LMB Named Lectures
  • LMB Exhibitions
    • Sample holders for electron cryomicroscopy
    • Humira
    • Curios of 60 years of the LMB
  • Scientific Training
  • Information for Journalists
  • Scientific Glossary
  • Photographs
  • LMB 365
  • Newspaper Archive

Search

  • Privacy & Cookies
  • Contact Directory
  • Freedom of Information
  • Site Map
Find Us
©2023 MRC Laboratory of Molecular Biology,
Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK. 01223 267000

The MRC is part of UK Research and Innovation

Contact Us